Article Text

other Versions

Download PDFPDF
Correspondence
Defining the need for a dynamic multimarker approach
  1. Simona Ferraro,
  2. Mauro Panteghini
  1. Dipartimento di Scienze Biomediche e Cliniche “Luigi Sacco”, Cattedra di Biochimica Clinica e Biologia Molecolare Clinica, Università degli Studi, Milano, Italy
  1. Correspondence to Dr Simona Ferraro, Dipartimento di Scienze Biomediche e Cliniche “Luigi Sacco”, Cattedra di Biochimica Clinica e Biologia Molecolare Clinica, Università degli Studi, Milano, Italy; ferraro.simona{at}hsacco.it.

Statistics from Altmetric.com

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.

To the Editor,

We read with great interest the recent article by Urbano-Moral et al1 evaluating the prognostic value of different serum biomarkers after ST-elevation myocardial infarction (STEMI). Although these findings may be compelling, as the companion editorial has highlighted,2 some pitfalls should be considered, including the sampling time suitable to gather the most reliable prognostic information. We recently published one study investigating the release kinetics and the time of peak of …

View Full Text

Footnotes

  • Contributors Both authors have contributed to the conception and design, acquisition, analysis and interpretation of data, drafting of the article and final approval for submission.

  • Funding None.

  • Competing interests None.

  • Patient consent Obtained.

  • Ethics approval IRB Ospedale Maggiore Novara Italy.

  • Provenance and peer review Not commissioned; internally peer reviewed.

Linked Articles